India to New Zealand: Salbutamol Export Trade Route

The India to New Zealand Salbutamol corridor is one of India's established pharmaceutical export routes, with 136 shipments documented worth a combined $4.0M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's salbutamol manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $29.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with salbutamol's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.7%, placing it at rank #3 among India's top salbutamol export destinations globally.

On the import side, key buyers of Indian salbutamol in New Zealand include REX MEDICAL LTD, REX MEDICAL LIMITED, REX MEDICAL LTD, and 5 others. REX MEDICAL LTD is the single largest importer with 45 shipments valued at $1.1M USD.

India's salbutamol exports to New Zealand are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 101 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , TULSI MEDICAL & GENERAL STORES — together account for 100% of total trade value on this route. The average shipment value of $29.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as salair (no dose counter)(salbutamol 100mcg) (1x200 md) and salair (no dose counter)(salbutamol 100mcg) 1 x 200 md, suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, REX MEDICAL LTD is the largest importer with 45 shipments worth $1.1M USD — representing 27% of all salbutamol imports from India on this route. A total of 8 buyers are active on this corridor.